These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26150452)

  • 1. Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia.
    Daniel DS; Lee SM; Dykes GA; Rahman S
    Appl Environ Microbiol; 2015 Sep; 81(18):6090-7. PubMed ID: 26150452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
    Leclercq R
    Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of multidrug-resistant enterococci in a tertiary care hospital in Mumbai, India.
    Deshpande VR; Karmarkar MG; Mehta PR
    J Infect Dev Ctries; 2013 Feb; 7(2):155-8. PubMed ID: 23416663
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycopeptide-resistant Enterococcus raffinosus in a haematology unit: an unusual cause of a nosocomial outbreak.
    Samuel J; Coutinho H; Galloway A; Rennison C; Kaufmann ME; Woodford N
    J Hosp Infect; 2008 Nov; 70(3):294-6. PubMed ID: 18783849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Enterococci: acquired antibiotic resistance].
    Alonso T; Pérez JL; Liñares J
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
    [No Abstract]   [Full Text] [Related]  

  • 6. [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].
    Cantón R; Ruiz-Garbajosa P
    Enferm Infecc Microbiol Clin; 2013 Oct; 31(8):543-51. PubMed ID: 24041416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Enterococci; increase in infection rate and antibiotic resistance].
    Thompson J
    Ned Tijdschr Geneeskd; 1996 Jan; 140(3):130-3. PubMed ID: 8618630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VRE--what every health care provider needs to know.
    Mikos-Schild S
    Todays Surg Nurse; 1998; 20(3):13-6; quiz 40-1. PubMed ID: 10026632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
    Cattoir V; Leclercq R
    J Antimicrob Chemother; 2013 Apr; 68(4):731-42. PubMed ID: 23208830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant enterococci: why are they here, and where do they come from?
    Bonten MJ; Willems R; Weinstein RA
    Lancet Infect Dis; 2001 Dec; 1(5):314-25. PubMed ID: 11871804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the control of glycopeptide-resistant enterococci in hospitals.
    Cookson BD; Macrae MB; Barrett SP; Brown DF; Chadwick C; French GL; Hateley P; Hosein IK; Wade JJ;
    J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of enterococci as a cause of nosocomial infection.
    Hunt CP
    Br J Biomed Sci; 1998 Jun; 55(2):149-56. PubMed ID: 10198473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity.
    Willems RJ; Bonten MJ
    Curr Opin Infect Dis; 2007 Aug; 20(4):384-90. PubMed ID: 17609597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
    Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
    J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
    Abamecha A; Wondafrash B; Abdissa A
    BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08.
    Bourdon N; Fines-Guyon M; Thiolet JM; Maugat S; Coignard B; Leclercq R; Cattoir V
    J Antimicrob Chemother; 2011 Apr; 66(4):713-21. PubMed ID: 21393182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.
    Ofner-Agostini M; Johnston BL; Simor AE; Embil J; Matlow A; Mulvey M; Ormiston D; Conly J;
    Infect Control Hosp Epidemiol; 2008 Mar; 29(3):271-4. PubMed ID: 18241031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-resistant enterococci: implications for infection control.
    Molyneux R; Chadwick C
    Prof Nurse; 1997 Jun; 12(9):641-4. PubMed ID: 9248438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance. Nosocomial gram-positive infection.
    Cookson B; Morrison D; Marples R
    J Med Microbiol; 1997 Jun; 46(6):439-42. PubMed ID: 9379468
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.